Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

FBXO9 anticorps (AA 13-111) (Biotin)

FBXO9 Reactivité: Humain ELISA Hôte: Lapin Polyclonal Biotin
N° du produit ABIN7152452
  • Antigène Voir toutes FBXO9 Anticorps
    FBXO9 (F-Box Protein 9 (FBXO9))
    Épitope
    • 15
    • 9
    • 8
    • 6
    • 4
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 13-111
    Reactivité
    • 42
    • 20
    • 15
    • 11
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 53
    • 4
    Lapin
    Clonalité
    • 55
    • 2
    Polyclonal
    Conjugué
    • 21
    • 5
    • 5
    • 5
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp FBXO9 est conjugé à/à la Biotin
    Application
    • 41
    • 29
    • 14
    • 13
    • 13
    • 7
    • 6
    • 5
    • 3
    • 1
    • 1
    ELISA
     Réactivité croisée
    Humain
    Purification
    >95%, Protein G purified
    Immunogène
    Recombinant Human F-box only protein 9 protein (13-111AA)
    Isotype
    IgG
    Top Product
    Discover our top product FBXO9 Anticorps primaire
  • Indications d'application
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
    Agent conservateur
    ProClin
    Précaution d'utilisation
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène
    FBXO9 (F-Box Protein 9 (FBXO9))
    Autre désignation
    FBXO9 (FBXO9 Produits)
    Synonymes
    anticorps fbxo9, anticorps MGC75727, anticorps FBXO9, anticorps fbx9, anticorps FBX9, anticorps NY-REN-57, anticorps VCIA1, anticorps dJ341E18.2, anticorps wu:fc79g12, anticorps zgc:56212, anticorps zgc:77654, anticorps 9030401P18Rik, anticorps AA986398, anticorps F-box protein 9, anticorps F-box only protein 9, anticorps f-box protein 9, anticorps F-box protein 9 L homeolog, anticorps fbxo9, anticorps FBXO9, anticorps CpipJ_CPIJ012920, anticorps Tsp_03945, anticorps fbx9, anticorps Fbxo9, anticorps fbxo9.L
    Sujet

    Background: Substrate recognition component of a SCF (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of TTI1 and TELO2 in a CK2-dependent manner, thereby directly regulating mTOR signaling. SCF(FBXO9) recognizes and binds mTORC1-bound TTI1 and TELO2 when they are phosphorylated by CK2 following growth factor deprivation, leading to their degradation. In contrast, the SCF(FBXO9) does not mediate ubiquitination of TTI1 and TELO2 when they are part of the mTORC2 complex. As a consequence, mTORC1 is inactivated to restrain cell growth and protein translation, while mTORC2 is activated due to the relief of feedback inhibition by mTORC1.

    Aliases: Cross-immune reaction antigen 1 antibody, dJ341E18.2 antibody, DKFZp434C0118 antibody, F-box only protein 9 antibody, Fbp24 antibody, FBX09 antibody, FBX9 antibody, FBX9_HUMAN antibody, Fbxo9 antibody, KIAA0936 antibody, NY REN 57 antibody, OTTHUMP00000016628 antibody, OTTHUMP00000016629 antibody, OTTHUMP00000214588 antibody, Renal carcinoma antigen NY-REN-57 antibody, VCIA1 antibody

    UniProt
    Q9UK97
Vous êtes ici:
Support technique